Midazolam and Soliris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Midazolam (midazolam) and Soliris (eculizumab). Common drug interactions include aplastic anaemia among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Midazolam and Soliris. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Soliris?

Soliris has active ingredients of eculizumab. It is often used in paroxysmal nocturnal hemoglobinuria (pnh). eHealthMe is studying from 58,821 Soliris users. Check the latest studies of Soliris.



On Jul, 17, 2026

13 people who take Midazolam and Soliris together, and have interactions are studied.

Midazolam and Soliris drug interactions.

What are the common drug interactions of Midazolam and Soliris, by gender? *:

female:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Death
  3. Herpes zoster
  4. Renal failure (kidney dysfunction)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)

male:

  1. Acute respiratory failure
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Encephalitis autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain)
  4. Renal cancer metastatic (cancer of kidney spreads to other part)
  5. Septic shock (shock due to blood infection)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Intravascular haemolysis (intravascular rupture of red blood cells with the release of haemoglobin and the cellular constituents into the plasma, or liquid portion of whole blood)
  8. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  9. Mitral valve incompetence (inefficient heart valve)
  10. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)

What are the common drug interactions of Midazolam and Soliris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Acute respiratory failure
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Diarrhoea
  4. Hepatic enzyme increased
  5. Nausea (feeling of having an urge to vomit)
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Respiratory distress (difficulty in breathing)
  8. Venoocclusive liver disease (small veins in the liver are obstructed)
  9. Vomiting
  10. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Herpes zoster
  3. Complement factor increased
  4. Encephalitis autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain)
  5. Septic shock (shock due to blood infection)
  6. Renal failure (kidney dysfunction)

50-59:

  1. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  2. Intravascular haemolysis (intravascular rupture of red blood cells with the release of haemoglobin and the cellular constituents into the plasma, or liquid portion of whole blood)
  3. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  4. Mitral valve incompetence (inefficient heart valve)
  5. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)

60+:

n/a

What are the existing conditions these people have? *

  1. Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 2 people, 15.38%
  2. Swallowing Pain Or Burning: 2 people, 15.38%
  3. Pressure Ulcer: 2 people, 15.38%
  4. Diarrhea: 2 people, 15.38%
  5. Cytomegalovirus Infection: 2 people, 15.38%
  6. Constipation: 2 people, 15.38%
  7. Venoocclusive Disease (small veins in the liver are obstructed): 1 person, 7.69%
  8. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 7.69%
  9. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 7.69%
  10. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and Soliris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Midazolam and Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soliris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Midazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soliris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on midazolam and eculizumab (the active ingredients of Midazolam and Soliris, respectively), and Midazolam and Soliris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: